查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1969422

不孕症治療旅遊市場：依治療類型、病患類型、治療週期類型、支付方式和醫療機構分類－2026年至2032年全球預測

Fertility Tourism Market by Treatment Type, Patient Type, Cycle Type, Payment Mode, Provider - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，生育治療旅遊市場價值將達到 5.1415 億美元，到 2026 年將成長到 5.747 億美元，到 2032 年將達到 12.0973 億美元，複合年成長率為 13.00%。

主要市場統計數據
基準年 2025 5.1415億美元
預計年份：2026年 5.747億美元
預測年份 2032 12.0973億美元
複合年成長率 (%) 13.00%

對現代全球不孕症治療旅遊進行簡要說明，包括臨床技術的進步、患者的動機、監管的多樣性以及跨境治療途徑。

國際生殖醫學處於臨床創新、病患自主權和跨境監管的交匯點，正在改變家庭跨越國界追求為人父母的方式。

技術創新、患者群體多樣化和虛擬護理模式如何重塑醫療保健提供者的策略以及跨國生育護理的提供方式。

不孕症治療旅遊的格局正在經歷一場變革，其驅動力包括臨床創新、患者群體多樣化和新的服務模式，這些變革正在重新定義醫療服務提供者的競爭優勢。

貿易政策變化對生殖保健服務的供應連續性、臨床運作、病患目的地選擇和供應商籌資策略的多方面影響。

改變醫療設備、生物材料及相關耗材貿易關稅的政策轉變，可能會對整個生育治療旅遊生態系統產生連鎖反應，影響供應鏈、定價動態和供應商行為。

多維細分分析，解釋了治療路徑、患者人口統計特徵、治療方法週期、提供者類別和支付機制如何影響策略選擇。

結構化細分分析揭示了治療、患者、週期、捐贈者和支付等維度上的服務特徵和策略需求。依治療類型分類的分析包括卵子捐贈、卵胞漿內單一精子注射（ICSI）、體外受精（IVF）、精子捐贈和代孕。卵子捐贈進一步細分為新鮮卵子捐贈和冷凍卵子捐贈；IVF細分為傳統IVF和胞漿內單一精子注射（IMSI）技術；精子捐贈細分為新鮮精子捐贈和冷凍精子捐贈；代孕細分為妊娠代孕和傳統代孕。每種治療方式都有其獨特的臨床流程、捐贈者管理通訊協定以及影響患者選擇和捐贈者專業水平的跨境法律考量。

決定生殖醫學服務中病患流動性、提供者定位和跨境醫療走廊的區域間比較趨勢和目的地特徵。

區域趨勢差異顯著，法規環境、臨床專長和患者偏好為入境和出境生育治療提供了不同的機會。在美洲，不同司法管轄區的監管差異與卓越的臨床中心和成熟的國際轉診體系並存。患者在選擇目的地時，通常會比較法律認可度、治療等待時間和患者對臨床品質的認知，而門戶市場的醫療機構則透過強調透明的治療結果報告和一體化的患者後勤物流來吸引國際患者。

診所網路、實驗室、數位平台和服務創新公司如何整合臨床品質、採購能力和病患體驗，以抓住跨境機會。

全球生殖健康服務生態系統中的領先機構整合了臨床護理、實驗室服務、診斷和患者導航能力，以提供全面的跨境服務和差異化的患者體驗。

為供應商和合作夥伴提供可操作的策略挑戰，以增強合規性、供應彈性、數位化醫療、透明的治療結果和以患者為中心的財務解決方案。

產業領導者需要採取積極措施，增強營運韌性，提升患者信心，並最佳化商業模式，以應對跨境挑戰。首先，投資建設完善的監管資訊和合規基礎設施，使臨床團隊和法律負責人能夠快速應對司法管轄區的變化，並在捐贈管理和代孕合約中維護道德標準。其次，實現關鍵耗材和檢測設備供應鏈多元化，同時建立本地冗餘機制，降低貿易中斷和關稅影響所帶來的風險。

我們採用高度透明的混合調查方法，結合關鍵相關人員的訪談、二手資料的整合、資料檢驗和情境分析來檢驗研究結果。

本報告的研究整合是基於混合方法，該方法將與主要相關人員的互動與嚴謹的二次分析和交叉檢驗相結合。主要研究包括對臨床醫生、檢查室管理人員、患者導航員和機構決策者進行結構化訪談，並輔以對患者和捐贈者計畫協調員的詳細定性訪談，以了解真實世界的體驗和服務痛點。這些直接觀點為假設的生成提供了依據，並指導了有針對性的二次研究活動。

策略整合突顯了臨床進步、患者主導的需求、監管複雜性和營運選擇之間的相互作用，這些因素共同塑造了生殖醫學的未來。

在臨床創新、病患賦權和日益複雜的監管等多種因素的共同推動下，全球生殖醫學持續發展，這不僅為醫療服務提供者和政策制定者帶來了機遇，也帶來了責任。臨床主導的檢測和冷凍保存技術的進步正在拓展可用的治療途徑，而患者群體的多樣化也增加了對捐精服務、代孕安排和專業諮詢的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：依治療方法分類的不孕症治療旅遊市場

  • 捐卵子
    • 提供新鮮卵子
    • 冷凍捐卵子
  • ICSI
  • 體外受精（IVF）
    • 常規體外受精
    • IMSI
  • 精子捐贈
    • 新鮮精子捐獻
    • 冷凍捐贈精子
  • 代孕
    • 懷孕和代孕
    • 傳統代孕

第9章：依病患類型分類的不孕症治療旅遊市場

  • 異性戀夫婦
  • 同性伴侶
  • 單身男士
  • 單身女性

第10章：按週期類型分類的不孕症治療旅遊市場

  • 新鮮胚胎移植週期
  • 冷凍胚胎移植週期
    • 冷凍保存
    • 解凍胚胎移植

第11章：不孕症治療旅遊市場：依支付方式分類

  • 融資
  • 保險
  • 自費

第12章：不孕症治療旅遊市場（依服務提供者分類）

  • 診斷檢查室
  • 不孕症治療診所
  • 醫院

第13章：不孕症治療旅遊市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：不孕症治療旅遊市場：依群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：不孕症治療旅遊市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國不孕症治療旅遊市場

第17章：中國不孕症治療旅遊市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Alpha IVF & Women's Specialists
  • Apollo Fertility
  • Barcelona IVF
  • Bourn Hall International Limited
  • CARE Fertility Group Limited
  • CCRM Fertility, Inc.
  • Eva Fertility Clinics
  • Genesis IVF
  • Indira IVF Limited
  • IVI-RMA Global, SL
  • Monash IVF Group Limited
  • Nova IVF Fertility Limited
  • Reprofit International sro
  • RMA Network, Inc.
  • Virtus Health Limited
Product Code: MRR-535C629188F8

The Fertility Tourism Market was valued at USD 514.15 million in 2025 and is projected to grow to USD 574.70 million in 2026, with a CAGR of 13.00%, reaching USD 1,209.73 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 514.15 million
Estimated Year [2026] USD 574.70 million
Forecast Year [2032] USD 1,209.73 million
CAGR (%) 13.00%

A concise orientation to the modern global fertility tourism ecosystem that explains clinical advances, patient motivations, regulatory diversity, and cross-border care pathways

International reproductive care increasingly sits at the intersection of clinical innovation, patient agency, and cross-border regulation, reshaping how families pursue parenthood beyond national boundaries.

Patients travel to access a broader array of treatments and to reconcile legal, financial, and clinical constraints at home. Advances in assisted reproductive technologies, including improvements in ovarian stimulation protocols, refined micromanipulation techniques, and more reliable cryopreservation methods, have enhanced clinical options and informed patient choice. Concurrently, digital triage, remote consultations, and secure data sharing are reducing the friction of pre- and post-procedure care, enabling care pathways that span multiple jurisdictions.

Regulatory regimes remain heterogeneous, with some countries offering permissive frameworks for donor gametes and surrogacy and others maintaining restrictive approaches. This regulatory diversity creates both opportunities and ethical complexities for providers and patients seeking cross-border solutions. Consequently, providers and policy makers must navigate quality assurance, accreditation, informed consent standards, and patient safety protocols while responding to evolving patient expectations and technological capabilities. Taken together, these dynamics form the foundational context for strategic planning and operational design in the global reproductive services arena.

How technological advances, patient demographic diversification, and virtual care models are reshaping provider strategies and cross-border fertility care delivery

The fertility tourism landscape is undergoing transformative shifts driven by clinical innovation, patient demographics, and new delivery models that are redefining competitive advantage for providers.

Technological advances such as refinements in intracytoplasmic sperm injection, optimized embryo selection techniques, and robust cryopreservation protocols have widened the therapeutic repertoire available to patients traveling for care. At the same time, patient cohorts have diversified: increasing numbers of same sex couples and single parents are seeking assisted reproductive services alongside traditional heterosexual couples, which amplifies demand for donor services and surrogacy arrangements. Financing mechanisms and insurance navigation are evolving in parallel, prompting providers to reconfigure payment pathways to include tailored financing plans and bundled care offerings.

Operationally, telemedicine and virtual care coordination have become central to pre-procedural evaluation and follow-up, enabling clinics to support international patients across time zones and regulatory regimes. Moreover, quality assurance and transparent outcome reporting are emerging as differentiators, with accredited laboratories and clinic networks leveraging data to build trust. As these shifts accelerate, stakeholders must balance ethical stewardship, regulatory compliance, and patient-centric service design to remain competitive and resilient.

The multifaceted effects of trade policy changes on supply continuity, clinical operations, patient destination choices, and provider sourcing strategies in reproductive services

Policy shifts that alter trade tariffs on medical devices, biological materials, and related consumables can have cascading effects across the fertility tourism ecosystem, influencing supply chains, pricing dynamics, and provider behavior.

When import duties or tariffs increase the landed cost of specialized laboratory equipment, cryopreservation supplies, or donor gametes, clinics that rely on internationally sourced inputs face higher operating expenses and potential service reconfiguration. In response, providers may pursue alternative sourcing strategies, accelerate local capacity development for laboratory supplies and reproductive materials, or renegotiate supplier agreements to mitigate margin pressure. Consequently, some patients may shift their destination choice to markets where service affordability and supply continuity remain intact, while other jurisdictions may actively seek to position themselves as competitive hubs by incentivizing domestic production or streamlining regulatory approvals for critical reproductive technologies.

Additionally, tariffs can indirectly affect clinical scheduling and logistics by lengthening procurement lead times and increasing inventory carrying costs for perishable or single-use items. In turn, facilities may prioritize treatments that are less supply-dependent or adapt clinical protocols to optimize resource utilization without compromising outcomes. Throughout these adjustments, regulatory alignment, transparent pricing communication, and patient consent practices become increasingly important to maintain trust and to ensure continuity of care amid changing trade conditions.

A multi-dimensional segmentation analysis explaining how treatment pathways, patient cohorts, cycle modalities, provider categories, and payment mechanisms shape strategic choices

A structured segmentation lens reveals distinct service dynamics and strategic imperatives across treatment, patient, cycle, provider, and payment dimensions. When analyzed by treatment type, the landscape encompasses egg donation, ICSI, IVF, sperm donation, and surrogacy, with egg donation further distinguished by fresh donor egg and frozen donor egg models, IVF parsed into conventional IVF and IMSI techniques, sperm donation divided into fresh and frozen donor sperm options, and surrogacy differentiated between gestational and traditional approaches; each of these treatment variants carries unique clinical workflows, donor management protocols, and cross-border legal considerations that influence patient choice and provider specialization.

Viewed through patient type, demand drivers differ markedly across heterosexual couples, same sex couples, single men, and single women, with implications for donor registry practices, counseling services, and ancillary support such as legal and psychosocial resources. Cycle type segmentation highlights operational and clinical trade-offs between fresh cycles and frozen cycles; frozen cycles themselves rely on cryopreservation capacity and thawed transfer pathways, which shape clinic scheduling, laboratory throughput, and patient counseling timelines.

Provider type segmentation distinguishes diagnostic laboratories, fertility clinics, and hospitals, each bringing varied scale economics, accreditation responsibilities, and care continuity models that affect referral networks and partnership opportunities. Finally, payment mode segmentation-spanning financing, insurance, and out-of-pocket arrangements-affects patient access, treatment uptake patterns, and the design of sales and support offerings. Taken together, these segmentation layers inform productization, patient journey design, and strategic investment priorities for stakeholders operating in the cross-border reproductive services arena.

Comparative regional dynamics and destination characteristics that determine patient flows, provider positioning, and cross-border care corridors in reproductive services

Regional dynamics vary considerably and create differentiated opportunity sets for inbound and outbound fertility travel, driven by regulatory environments, clinical specialization, and patient preferences. In the Americas, regulatory heterogeneity across jurisdictions coexists with centers of clinical excellence and established international referral flows; patients frequently weigh legal permissiveness, time-to-treatment, and perceived clinical quality when selecting destinations, and providers in gateway markets emphasize transparent outcomes reporting and integrated patient logistics to attract international clients.

Across Europe, the Middle East, and Africa, a mosaic of legal frameworks and cultural perspectives produces a diverse set of hubs and corridors for reproductive care. Some European jurisdictions serve as centers for donor services and specialized laboratory techniques, while select countries in the Middle East offer high-capacity clinical programs oriented to regional demand. In parts of Africa, emerging facilities aim to capture regional patient flows by investing in laboratory accreditation and clinician training. Each sub-region balances ethical considerations, cross-border legal arrangements, and translational research collaboration to enhance service offerings.

The Asia-Pacific region exhibits rapid capability development in both metropolitan medical centers and specialist clinics, supported by investments in laboratory infrastructure and patient-facing digital platforms. Southeast Asian clinics, in particular, have become attractive for cost-sensitive international patients, whereas advanced clinical and technological competencies in other APAC markets are drawing medically complex cases. Across all regions, regulatory transparency, traveler support services, and reputational quality are decisive factors for patients contemplating cross-border reproductive care.

How clinic networks, laboratories, digital platforms, and service innovators are aligning clinical quality, procurement resilience, and patient experience to capture cross-border opportunities

Leading organizations in the global reproductive services ecosystem are consolidating capabilities across clinical care, laboratory services, diagnostics, and patient navigation to deliver integrated cross-border offerings and differentiated patient experiences.

Healthcare groups and clinic networks are focusing on vertical integration to reduce operational risk from fragmented supply chains and to standardize quality across multiple sites. Diagnostic laboratories and specialized service providers are investing in advanced embryology equipment and accreditation to support higher complexity procedures and to enable outcome transparency. At the same time, medical device and consumable suppliers are targeting partnerships with clinic chains and national associations to secure long-term procurement commitments and to support local training initiatives.

Service innovators are also building digital front doors that combine telemedicine, multilingual patient coordination, and secure record exchange to simplify international patient journeys. Financial service providers that tailor lending and payment plans to reproductive care needs are creating smoother payment pathways, increasing treatment accessibility for price-sensitive segments. Overall, companies that prioritize regulatory compliance, clinical quality metrics, and patient-centric operations are better positioned to capture long-term patient loyalty and to participate in strategic cross-border partnerships.

Practical strategic imperatives for providers and partners to enhance compliance, supply resilience, digital care, transparent outcomes, and patient-centric financing solutions

Industry leaders must take deliberate steps to strengthen operational resilience, improve patient trust, and optimize commercial models that align with cross-border realities. First, invest in comprehensive regulatory intelligence and compliance infrastructure so that clinical teams and legal counsel can rapidly adapt to jurisdictional changes and maintain ethical standards for donor management and surrogacy arrangements. Second, diversify supply chains for critical consumables and laboratory equipment while building local redundancy to reduce exposure to trade disruptions and tariff impacts.

Third, expand telemedicine and remote care capabilities to streamline pre-treatment evaluation and post-procedural follow-up, thereby increasing capacity to manage international patients without compromising continuity of care. Fourth, develop transparent outcome reporting and standardized quality metrics to build reputational distinction and to support informed patient decision making across borders. Fifth, design flexible payment constructs, including tailored financing options and bundled pricing, to address affordability constraints and to broaden access across diverse patient types. Finally, prioritize patient experience investments such as multilingual coordination, legal counseling partnerships, and culturally competent support services to improve conversion and retention among international cohorts. These measures, taken together, can materially strengthen competitive positioning while safeguarding clinical excellence and patient safety.

A transparent mixed-methods research approach that combines primary stakeholder interviews, secondary literature synthesis, data triangulation, and scenario analysis to validate insights

The research synthesis underpinning this report draws on a mixed-methods approach that integrates primary stakeholder engagement with rigorous secondary analysis and cross-validation. Primary research involved structured interviews with clinicians, laboratory directors, patient navigators, and institutional decision makers, supplemented by in-depth qualitative interviews with patients and donor program coordinators to capture lived experiences and service friction points. These firsthand perspectives informed hypothesis generation and guided targeted secondary research activities.

Secondary analysis encompassed a systematic review of peer-reviewed clinical literature, regulatory texts, professional society guidance, and publicly available operational standards for laboratories and clinics. Data triangulation employed multiple independent sources to validate procedural descriptions, quality initiatives, and technology adoption pathways. Methodologically, treatment and patient segment mapping were used to align service offerings with observed demand characteristics, while scenario analysis explored plausible operational responses to policy shifts and supply disruptions. Throughout the process, efforts were made to identify data gaps and to qualify conclusions where empirical evidence was limited, ensuring transparent and defensible insights for stakeholders.

A strategic synthesis that highlights the interplay between clinical progress, patient-driven demand, regulatory complexity, and the operational choices shaping future reproductive care

Global reproductive care continues to evolve under the combined influence of clinical innovation, patient empowerment, and regulatory complexity, creating both opportunity and responsibility for providers and policy makers. Clinically driven improvements in laboratory techniques and cryopreservation have expanded feasible treatment pathways, while diversification in patient demographics has increased demand for donor services, surrogacy arrangements, and specialized counseling.

At the same time, trade policy shifts and regional regulatory heterogeneity create operational challenges that require proactive supply chain management, compliance investment, and transparent patient communication. Providers that embrace integrated care models, invest in digital patient journeys, and commit to demonstrable quality metrics will be better positioned to attract international patients and to sustain clinical outcomes. In sum, success in the fertility tourism space will depend on a balanced strategy that prioritizes clinical excellence, ethical stewardship, and operational resilience while meeting the evolving needs of diverse patient populations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Fertility Tourism Market, by Treatment Type

  • 8.1. Egg Donation
    • 8.1.1. Fresh Donor Egg
    • 8.1.2. Frozen Donor Egg
  • 8.2. ICSI
  • 8.3. IVF
    • 8.3.1. Conventional IVF
    • 8.3.2. IMSI
  • 8.4. Sperm Donation
    • 8.4.1. Fresh Donor Sperm
    • 8.4.2. Frozen Donor Sperm
  • 8.5. Surrogacy
    • 8.5.1. Gestational Surrogacy
    • 8.5.2. Traditional Surrogacy

9. Fertility Tourism Market, by Patient Type

  • 9.1. Heterosexual Couples
  • 9.2. Same Sex Couples
  • 9.3. Single Men
  • 9.4. Single Women

10. Fertility Tourism Market, by Cycle Type

  • 10.1. Fresh Cycle
  • 10.2. Frozen Cycle
    • 10.2.1. Cryopreservation
    • 10.2.2. Thawed Transfer

11. Fertility Tourism Market, by Payment Mode

  • 11.1. Financing
  • 11.2. Insurance
  • 11.3. Out Of Pocket

12. Fertility Tourism Market, by Provider

  • 12.1. Diagnostic Laboratories
  • 12.2. Fertility Clinics
  • 12.3. Hospitals

13. Fertility Tourism Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Fertility Tourism Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Fertility Tourism Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Fertility Tourism Market

17. China Fertility Tourism Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Alpha IVF & Women's Specialists
  • 18.6. Apollo Fertility
  • 18.7. Barcelona IVF
  • 18.8. Bourn Hall International Limited
  • 18.9. CARE Fertility Group Limited
  • 18.10. CCRM Fertility, Inc.
  • 18.11. Eva Fertility Clinics
  • 18.12. Genesis IVF
  • 18.13. Indira IVF Limited
  • 18.14. IVI-RMA Global, S.L.
  • 18.15. Monash IVF Group Limited
  • 18.16. Nova IVF Fertility Limited
  • 18.17. Reprofit International s.r.o.
  • 18.18. RMA Network, Inc.
  • 18.19. Virtus Health Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL FERTILITY TOURISM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FERTILITY TOURISM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FERTILITY TOURISM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FERTILITY TOURISM MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FERTILITY TOURISM MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FERTILITY TOURISM MARKET SIZE, BY CYCLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FERTILITY TOURISM MARKET SIZE, BY PAYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FERTILITY TOURISM MARKET SIZE, BY PROVIDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FERTILITY TOURISM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FERTILITY TOURISM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL FERTILITY TOURISM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES FERTILITY TOURISM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA FERTILITY TOURISM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FERTILITY TOURISM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FERTILITY TOURISM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FERTILITY TOURISM MARKET SIZE, BY EGG DONATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FERTILITY TOURISM MARKET SIZE, BY EGG DONATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FERTILITY TOURISM MARKET SIZE, BY EGG DONATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FERTILITY TOURISM MARKET SIZE, BY EGG DONATION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FRESH DONOR EGG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FRESH DONOR EGG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FRESH DONOR EGG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FROZEN DONOR EGG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FROZEN DONOR EGG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FROZEN DONOR EGG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FERTILITY TOURISM MARKET SIZE, BY ICSI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FERTILITY TOURISM MARKET SIZE, BY ICSI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FERTILITY TOURISM MARKET SIZE, BY ICSI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FERTILITY TOURISM MARKET SIZE, BY IVF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FERTILITY TOURISM MARKET SIZE, BY IVF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FERTILITY TOURISM MARKET SIZE, BY IVF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FERTILITY TOURISM MARKET SIZE, BY IVF, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FERTILITY TOURISM MARKET SIZE, BY CONVENTIONAL IVF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FERTILITY TOURISM MARKET SIZE, BY CONVENTIONAL IVF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FERTILITY TOURISM MARKET SIZE, BY CONVENTIONAL IVF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FERTILITY TOURISM MARKET SIZE, BY IMSI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FERTILITY TOURISM MARKET SIZE, BY IMSI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FERTILITY TOURISM MARKET SIZE, BY IMSI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FERTILITY TOURISM MARKET SIZE, BY SPERM DONATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FERTILITY TOURISM MARKET SIZE, BY SPERM DONATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FERTILITY TOURISM MARKET SIZE, BY SPERM DONATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FERTILITY TOURISM MARKET SIZE, BY SPERM DONATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FRESH DONOR SPERM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FRESH DONOR SPERM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FRESH DONOR SPERM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FROZEN DONOR SPERM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FROZEN DONOR SPERM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FROZEN DONOR SPERM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FERTILITY TOURISM MARKET SIZE, BY SURROGACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FERTILITY TOURISM MARKET SIZE, BY SURROGACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FERTILITY TOURISM MARKET SIZE, BY SURROGACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FERTILITY TOURISM MARKET SIZE, BY SURROGACY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FERTILITY TOURISM MARKET SIZE, BY GESTATIONAL SURROGACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FERTILITY TOURISM MARKET SIZE, BY GESTATIONAL SURROGACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FERTILITY TOURISM MARKET SIZE, BY GESTATIONAL SURROGACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FERTILITY TOURISM MARKET SIZE, BY TRADITIONAL SURROGACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FERTILITY TOURISM MARKET SIZE, BY TRADITIONAL SURROGACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FERTILITY TOURISM MARKET SIZE, BY TRADITIONAL SURROGACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FERTILITY TOURISM MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FERTILITY TOURISM MARKET SIZE, BY HETEROSEXUAL COUPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FERTILITY TOURISM MARKET SIZE, BY HETEROSEXUAL COUPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FERTILITY TOURISM MARKET SIZE, BY HETEROSEXUAL COUPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FERTILITY TOURISM MARKET SIZE, BY SAME SEX COUPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FERTILITY TOURISM MARKET SIZE, BY SAME SEX COUPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FERTILITY TOURISM MARKET SIZE, BY SAME SEX COUPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FERTILITY TOURISM MARKET SIZE, BY SINGLE MEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FERTILITY TOURISM MARKET SIZE, BY SINGLE MEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FERTILITY TOURISM MARKET SIZE, BY SINGLE MEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FERTILITY TOURISM MARKET SIZE, BY SINGLE WOMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FERTILITY TOURISM MARKET SIZE, BY SINGLE WOMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FERTILITY TOURISM MARKET SIZE, BY SINGLE WOMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FERTILITY TOURISM MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FRESH CYCLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FRESH CYCLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FRESH CYCLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FROZEN CYCLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FROZEN CYCLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FROZEN CYCLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FROZEN CYCLE, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FERTILITY TOURISM MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FERTILITY TOURISM MARKET SIZE, BY CRYOPRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FERTILITY TOURISM MARKET SIZE, BY CRYOPRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FERTILITY TOURISM MARKET SIZE, BY THAWED TRANSFER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FERTILITY TOURISM MARKET SIZE, BY THAWED TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FERTILITY TOURISM MARKET SIZE, BY THAWED TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FERTILITY TOURISM MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FINANCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FINANCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FINANCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FERTILITY TOURISM MARKET SIZE, BY INSURANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FERTILITY TOURISM MARKET SIZE, BY INSURANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL FERTILITY TOURISM MARKET SIZE, BY INSURANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FERTILITY TOURISM MARKET SIZE, BY OUT OF POCKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FERTILITY TOURISM MARKET SIZE, BY OUT OF POCKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FERTILITY TOURISM MARKET SIZE, BY OUT OF POCKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FERTILITY TOURISM MARKET SIZE, BY PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FERTILITY TOURISM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL FERTILITY TOURISM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL FERTILITY TOURISM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FERTILITY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL FERTILITY TOURISM MARKET SIZE, BY FERTILITY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL FERTILITY TOURISM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL FERTILITY TOURISM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FERTILITY TOURISM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FERTILITY TOURISM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS FERTILITY TOURISM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS FERTILITY TOURISM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS FERTILITY TOURISM MARKET SIZE, BY EGG DONATION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS FERTILITY TOURISM MARKET SIZE, BY IVF, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS FERTILITY TOURISM MARKET SIZE, BY SPERM DONATION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS FERTILITY TOURISM MARKET SIZE, BY SURROGACY, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS FERTILITY TOURISM MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS FERTILITY TOURISM MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS FERTILITY TOURISM MARKET SIZE, BY FROZEN CYCLE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS FERTILITY TOURISM MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS FERTILITY TOURISM MARKET SIZE, BY PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA FERTILITY TOURISM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA FERTILITY TOURISM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA FERTILITY TOURISM MARKET SIZE, BY EGG DONATION, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA FERTILITY TOURISM MARKET SIZE, BY IVF, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA FERTILITY TOURISM MARKET SIZE, BY SPERM DONATION, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA FERTILITY TOURISM MARKET SIZE, BY SURROGACY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA FERTILITY TOURISM MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA FERTILITY TOURISM MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA FERTILITY TOURISM MARKET SIZE, BY FROZEN CYCLE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA FERTILITY TOURISM MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA FERTILITY TOURISM MARKET SIZE, BY PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA FERTILITY TOURISM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA FERTILITY TOURISM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA FERTILITY TOURISM MARKET SIZE, BY EGG DONATION, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA FERTILITY TOURISM MARKET SIZE, BY IVF, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA FERTILITY TOURISM MARKET SIZE, BY SPERM DONATION, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA FERTILITY TOURISM MARKET SIZE, BY SURROGACY, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA FERTILITY TOURISM MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA FERTILITY TOURISM MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA FERTILITY TOURISM MARKET SIZE, BY FROZEN CYCLE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA FERTILITY TOURISM MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA FERTILITY TOURISM MARKET SIZE, BY PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA FERTILITY TOURISM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA FERTILITY TOURISM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA FERTILITY TOURISM MARKET SIZE, BY EGG DONATION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA FERTILITY TOURISM MARKET SIZE, BY IVF, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA FERTILITY TOURISM MARKET SIZE, BY SPERM DONATION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA FERTILITY TOURISM MARKET SIZE, BY SURROGACY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA FERTILITY TOURISM MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA FERTILITY TOURISM MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA FERTILITY TOURISM MARKET SIZE, BY FROZEN CYCLE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA FERTILITY TOURISM MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA FERTILITY TOURISM MARKET SIZE, BY PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE FERTILITY TOURISM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE FERTILITY TOURISM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE FERTILITY TOURISM MARKET SIZE, BY EGG DONATION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE FERTILITY TOURISM MARKET SIZE, BY IVF, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE FERTILITY TOURISM MARKET SIZE, BY SPERM DONATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE FERTILITY TOURISM MARKET SIZE, BY SURROGACY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE FERTILITY TOURISM MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE FERTILITY TOURISM MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE FERTILITY TOURISM MARKET SIZE, BY FROZEN CYCLE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE FERTILITY TOURISM MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE FERTILITY TOURISM MARKET SIZE, BY PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST FERTILITY TOURISM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST FERTILITY TOURISM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST FERTILITY TOURISM MARKET SIZE, BY EGG DONATION, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST FERTILITY TOURISM MARKET SIZE, BY IVF, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST FERTILITY TOURISM MARKET SIZE, BY SPERM DONATION, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST FERTILITY TOURISM MARKET SIZE, BY SURROGACY, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST FERTILITY TOURISM MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST FERTILITY TOURISM MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST FERTILITY TOURISM MARKET SIZE, BY FROZEN CYCLE, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST FERTILITY TOURISM MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST FERTILITY TOURISM MARKET SIZE, BY PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA FERTILITY TOURISM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA FERTILITY TOURISM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA FERTILITY TOURISM MARKET SIZE, BY EGG DONATION, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA FERTILITY TOURISM MARKET SIZE, BY IVF, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA FERTILITY TOURISM MARKET SIZE, BY SPERM DONATION, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA FERTILITY TOURISM MARKET SIZE, BY SURROGACY, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA FERTILITY TOURISM MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA FERTILITY TOURISM MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA FERTILITY TOURISM MARKET SIZE, BY FROZEN CYCLE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA FERTILITY TOURISM MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA FERTILITY TOURISM MARKET SIZE, BY PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC FERTILITY TOURISM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC FERTILITY TOURISM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC FERTILITY TOURISM MARKET SIZE, BY EGG DONATION, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC FERTILITY TOURISM MARKET SIZE, BY IVF, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC FERTILITY TOURISM MARKET SIZE, BY SPERM DONATION, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC FERTILITY TOURISM MARKET SIZE, BY SURROGACY, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC FERTILITY TOURISM MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC FERTILITY TOURISM MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC FERTILITY TOURISM MARKET SIZE, BY FROZEN CYCLE, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC FERTILITY TOURISM MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC FERTILITY TOURISM MARKET SIZE, BY PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL FERTILITY TOURISM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN FERTILITY TOURISM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN FERTILITY TOURISM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN FERTILITY TOURISM MARKET SIZE, BY EGG DONATION, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN FERTILITY TOURISM MARKET SIZE, BY IVF, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN FERTILITY TOURISM MARKET SIZE, BY SPERM DONATION, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN FERTILITY TOURISM MARKET SIZE, BY SURROGACY, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN FERTILITY TOURISM MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN FERTILITY TOURISM MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN FERTILITY TOURISM MARKET SIZE, BY FROZEN CYCLE, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN FERTILITY TOURISM MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN FERTILITY TOURISM MARKET SIZE, BY PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 194. GCC FERTILITY TOURISM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. GCC FERTILITY TOURISM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. GCC FERTILITY TOURISM MARKET SIZE, BY EGG DONATION, 2018-2032 (USD MILLION)
  • TABLE 197. GCC FERTILITY TOURISM MARKET SIZE, BY IVF, 2018-2032 (USD MILLION)
  • TABLE 198. GCC FERTILITY TOURISM MARKET SIZE, BY SPERM DONATION, 2018-2032 (USD MILLION)
  • TABLE 199. GCC FERTILITY TOURISM MARKET SIZE, BY SURROGACY, 2018-2032 (USD MILLION)
  • TABLE 200. GCC FERTILITY TOURISM MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. GCC FERTILITY TOURISM MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. GCC FERTILITY TOURISM MARKET SIZE, BY FROZEN CYCLE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC FERTILITY TOURISM MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 204. GCC FERTILITY TOURISM MARKET SIZE, BY PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION FERTILITY TOURISM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION FERTILITY TOURISM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION FERTILITY TOURISM MARKET SIZE, BY EGG DONATION, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION FERTILITY TOURISM MARKET SIZE, BY IVF, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION FERTILITY TOURISM MARKET SIZE, BY SPERM DONATION, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION FERTILITY TOURISM MARKET SIZE, BY SURROGACY, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION FERTILITY TOURISM MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION FERTILITY TOURISM MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION FERTILITY TOURISM MARKET SIZE, BY FROZEN CYCLE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION FERTILITY TOURISM MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION FERTILITY TOURISM MARKET SIZE, BY PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS FERTILITY TOURISM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS FERTILITY TOURISM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS FERTILITY TOURISM MARKET SIZE, BY EGG DONATION, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS FERTILITY TOURISM MARKET SIZE, BY IVF, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS FERTILITY TOURISM MARKET SIZE, BY SPERM DONATION, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS FERTILITY TOURISM MARKET SIZE, BY SURROGACY, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS FERTILITY TOURISM MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS FERTILITY TOURISM MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS FERTILITY TOURISM MARKET SIZE, BY FROZEN CYCLE, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS FERTILITY TOURISM MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS FERTILITY TOURISM MARKET SIZE, BY PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 227. G7 FERTILITY TOURISM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. G7 FERTILITY TOURISM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. G7 FERTILITY TOURISM MARKET SIZE, BY EGG DONATION, 2018-2032 (USD MILLION)
  • TABLE 230. G7 FERTILITY TOURISM MARKET SIZE, BY IVF, 2018-2032 (USD MILLION)
  • TABLE 231. G7 FERTILITY TOURISM MARKET SIZE, BY SPERM DONATION, 2018-2032 (USD MILLION)
  • TABLE 232. G7 FERTILITY TOURISM MARKET SIZE, BY SURROGACY, 2018-2032 (USD MILLION)
  • TABLE 233. G7 FERTILITY TOURISM MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. G7 FERTILITY TOURISM MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. G7 FERTILITY TOURISM MARKET SIZE, BY FROZEN CYCLE, 2018-2032 (USD MILLION)
  • TABLE 236. G7 FERTILITY TOURISM MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 237. G7 FERTILITY TOURISM MARKET SIZE, BY PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 238. NATO FERTILITY TOURISM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. NATO FERTILITY TOURISM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. NATO FERTILITY TOURISM MARKET SIZE, BY EGG DONATION, 2018-2032 (USD MILLION)
  • TABLE 241. NATO FERTILITY TOURISM MARKET SIZE, BY IVF, 2018-2032 (USD MILLION)
  • TABLE 242. NATO FERTILITY TOURISM MARKET SIZE, BY SPERM DONATION, 2018-2032 (USD MILLION)
  • TABLE 243. NATO FERTILITY TOURISM MARKET SIZE, BY SURROGACY, 2018-2032 (USD MILLION)
  • TABLE 244. NATO FERTILITY TOURISM MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. NATO FERTILITY TOURISM MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. NATO FERTILITY TOURISM MARKET SIZE, BY FROZEN CYCLE, 2018-2032 (USD MILLION)
  • TABLE 247. NATO FERTILITY TOURISM MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 248. NATO FERTILITY TOURISM MARKET SIZE, BY PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL FERTILITY TOURISM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES FERTILITY TOURISM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES FERTILITY TOURISM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES FERTILITY TOURISM MARKET SIZE, BY EGG DONATION, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES FERTILITY TOURISM MARKET SIZE, BY IVF, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES FERTILITY TOURISM MARKET SIZE, BY SPERM DONATION, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES FERTILITY TOURISM MARKET SIZE, BY SURROGACY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES FERTILITY TOURISM MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES FERTILITY TOURISM MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES FERTILITY TOURISM MARKET SIZE, BY FROZEN CYCLE, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES FERTILITY TOURISM MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES FERTILITY TOURISM MARKET SIZE, BY PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA FERTILITY TOURISM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA FERTILITY TOURISM MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA FERTILITY TOURISM MARKET SIZE, BY EGG DONATION, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA FERTILITY TOURISM MARKET SIZE, BY IVF, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA FERTILITY TOURISM MARKET SIZE, BY SPERM DONATION, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA FERTILITY TOURISM MARKET SIZE, BY SURROGACY, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA FERTILITY TOURISM MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA FERTILITY TOURISM MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA FERTILITY TOURISM MARKET SIZE, BY FROZEN CYCLE, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA FERTILITY TOURISM MARKET SIZE, BY PAYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA FERTILITY TOURISM MARKET SIZE, BY PROVIDER, 2018-2032 (USD MILLION)